Budget Amount *help |
¥16,640,000 (Direct Cost: ¥12,800,000、Indirect Cost: ¥3,840,000)
Fiscal Year 2016: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2015: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2014: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
|
Outline of Final Research Achievements |
We investigated the role of escape mutants selected by HIV-1-specific CTLs in progression to AIDS. First, we analyzed HLA-associated mutations in 430 HIV-1-infected Japanese individuals. We found 283 HLA-associated mutations in our cohort. Five mutations associated with HLA-B52/C12 is associated with lower plasma viral load. In vitro analysis confirmed that these mutations were selected by HLA-B*52:01- or C*12:02-restricted CTLs and that the mutant viruses having these mutation has lower replication capacity than wild-type ones. The present study demonstrated that HLA-B52/C12 may control HIV-1 replication in individuals having these protective alleles and the mutation selected by these CTLs has low replication capacity, This is the mechanism of slow progression to AIDS in individuals having protective haplotype, HLA-B:52:01-C*12:02.
|